[HTML][HTML] Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial …
Background The multicentre, randomised, sham-controlled RADIANCE-HTN SOLO trial
reported the blood pressure (BP)-lowering efficacy and safety of ultrasound renal
denervation (RDN) in the absence (2 months) and presence (6 and 12 months) of
antihypertensive medications in patients with mild-to-moderate hypertension. Aims The aim
of this report was to evaluate patients originally assigned to the sham group who crossed
over to RDN. Methods After the primary endpoint was met, patients in the sham arm who …
reported the blood pressure (BP)-lowering efficacy and safety of ultrasound renal
denervation (RDN) in the absence (2 months) and presence (6 and 12 months) of
antihypertensive medications in patients with mild-to-moderate hypertension. Aims The aim
of this report was to evaluate patients originally assigned to the sham group who crossed
over to RDN. Methods After the primary endpoint was met, patients in the sham arm who …